The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination

Oligodendrocytes express opioid receptors throughout development, but the role of the opioid system in myelination remains poorly understood. This is a significant problem as opioid use and abuse continue to increase in two particular populations: pregnant addicts (in whom drug effects could target early myelination in the fetus and newborn) and adolescents and young adults (in whom late myelination of ‘higher-order' regions takes place). Maintenance treatments for opioid addicts include the long-lasting opioids methadone and buprenorphine. Similar to our previous findings on the effects of buprenorphine, we have now found that early myelination in the developing rat brain is also altered by perinatal exposure to therapeutic doses of methadone. Pups exposed to this drug exhibited elevated brain levels of the 4 major splicing variants of myelin basic protein, myelin proteolipid protein, and myelin-oligodendrocyte glycoprotein. Consistent with the enrichment and function of these proteins in mature myelin, analysis of the corpus callosum in these young animals also indicated an elevated number of axons with already highly compacted myelin sheaths. Moreover, studies in cultured cells showed that methadone exerts direct effects at specific stages of the oligodendrocyte lineage, stimulating the proliferation of progenitor cells while on the other hand accelerating the maturation of the more differentiated but still immature preoligodendrocytes. While the long-term effects of these observations remain unknown, accelerated or increased oligodendrocyte maturation and myelination could both disrupt the complex sequence of synchronized events leading to normal connectivity in the developing brain. Together with our previous observations on the effects of buprenorphine, the present findings further underscore a crucial function of the endogenous opioid system in the control of oligodendrocyte development and the timing of myelination. Interference with these regulatory systems by opioid use or maintenance treatments could disrupt the normal process of brain maturation at critical stages of myelin formation.

[1]  M. Nedergaard,et al.  White matter astrocytes in health and disease , 2014, Neuroscience.

[2]  B. Emery,et al.  Mechanisms regulating the development of oligodendrocytes and central nervous system myelin , 2014, Neuroscience.

[3]  Panos Roussos,et al.  Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities , 2014, Front. Cell. Neurosci..

[4]  L. Amato,et al.  Maintenance agonist treatments for opiate-dependent pregnant women. , 2013, The Cochrane database of systematic reviews.

[5]  T. Kerr,et al.  “Nonmedical” prescription opioid use in North America: a call for priority action , 2013, Substance Abuse Treatment, Prevention, and Policy.

[6]  K. Nave,et al.  The role of myelin and oligodendrocytes in axonal energy metabolism , 2013, Current Opinion in Neurobiology.

[7]  J. Rothstein,et al.  Oligodendroglia: metabolic supporters of axons. , 2013, Trends in cell biology.

[8]  Greg Freedman,et al.  Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[9]  P. Levounis,et al.  Safe Methadone Induction and Stabilization: Report of an Expert Panel , 2013, Journal of addiction medicine.

[10]  R. Cunningham,et al.  Nonmedical Prescription Opioid and Sedative Use Among Adolescents in the Emergency Department , 2013, Pediatrics.

[11]  J. Glanz,et al.  National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. , 2013, Drug and alcohol dependence.

[12]  D. Bajic,et al.  Morphine-enhanced apoptosis in selective brain regions of neonatal rats , 2013, International Journal of Developmental Neuroscience.

[13]  Brady T. West,et al.  Medical use, medical misuse, and nonmedical use of prescription opioids: Results from a longitudinal study , 2013, PAIN®.

[14]  J. Dieleman,et al.  Incidence rates and risk factors of bipolar disorder in the general population: a population‐based cohort study , 2013, Bipolar disorders.

[15]  B. Finlay,et al.  Modeling Transformations of Neurodevelopmental Sequences across Mammalian Species , 2013, The Journal of Neuroscience.

[16]  B. O'dowd,et al.  Striatal development involves a switch in gene expression networks, followed by a myelination event: Implications for neuropsychiatric disease , 2013, Synapse.

[17]  B. O'dowd,et al.  Striatal development involves a switch in gene expression networks, followed by a myelination event: implications for neuropsychiatric disease , 2013 .

[18]  J. Dieleman,et al.  Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study , 2013, Social Psychiatry and Psychiatric Epidemiology.

[19]  Daniel Rosenblum,et al.  Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993–2009 , 2013, PloS one.

[20]  S. Bilbo,et al.  Adolescent Morphine Exposure Affects Long-Term Microglial Function and Later-Life Relapse Liability in a Model of Addiction , 2013, The Journal of Neuroscience.

[21]  R. Watts,et al.  Neural tract development of infants born to methadone-maintained mothers. , 2012, Pediatric neurology.

[22]  A. Eschenroeder,et al.  Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ‐opioid‐ and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancy , 2012, Glia.

[23]  Scott T. Miller,et al.  Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes , 2011, American journal of hematology.

[24]  D. MacDonald,et al.  Accelerated myelination with motor system involvement in a neonate with immediate postnatal onset of seizures and hemimegalencephaly , 2011, Epilepsy & Behavior.

[25]  A. Melinder,et al.  Prenatal exposure to methadone and buprenorphine: A review of the potential effects on cognitive development , 2011, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.

[26]  H. Jones,et al.  Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. , 2011, Clinical chemistry.

[27]  V. Haroutunian,et al.  Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia , 2010, Schizophrenia Research.

[28]  C. Westin,et al.  Corpus Callosum Abnormalities and Their Association with Psychotic Symptoms in Patients with Schizophrenia , 2010, Biological Psychiatry.

[29]  R. Bodnar,et al.  Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: Central mechanisms of action and roles of gonadal hormones , 2010, Hormones and Behavior.

[30]  P. Szeszko,et al.  A role for white matter abnormalities in the pathophysiology of bipolar disorder , 2010, Neuroscience & Biobehavioral Reviews.

[31]  R. Wesselschmidt,et al.  Mu and kappa opioids modulate mouse embryonic stem cell‐derived neural progenitor differentiation via MAP kinases , 2010, Journal of neurochemistry.

[32]  C. Sato-Bigbee,et al.  Neurotrophin‐3 targets the translational initiation machinery in oligodendrocytes , 2009, Glia.

[33]  R. Skoff,et al.  Sexual dimorphism in the white matter of rodents , 2009, Journal of the Neurological Sciences.

[34]  Michele Tansella,et al.  White matter connectivity in bipolar disorder , 2009, International review of psychiatry.

[35]  R. Fields,et al.  Oligodendrocytes Changing the Rules: Action Potentials in Glia and Oligodendrocytes Controlling Action Potentials , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[36]  Kirstie J. Whitaker,et al.  Quantifying development: Investigating highly myelinated voxels in preadolescent corpus callosum , 2008, NeuroImage.

[37]  E. Sanchez,et al.  Opioid addiction and pregnancy: Perinatal exposure to buprenorphine affects myelination in the developing brain , 2008, Glia.

[38]  Ke Zhou,et al.  Diffusion tensor imaging of normal white matter maturation from late childhood to young adulthood: Voxel-wise evaluation of mean diffusivity, fractional anisotropy, radial and axial diffusivities, and correlation with reading development , 2008, NeuroImage.

[39]  S. Payne,et al.  The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors , 2007, Journal of Pharmacology and Experimental Therapeutics.

[40]  Christopher A Evans,et al.  EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS , 2006, Drug Metabolism and Disposition.

[41]  P. Eriksson,et al.  Requirement for Id1 in opioid‐induced oligodendrogenesis in cultured adult rat hippocampal progenitors , 2006, The European journal of neuroscience.

[42]  Nora D Volkow,et al.  Major increases in opioid analgesic abuse in the United States: concerns and strategies. , 2006, Drug and alcohol dependence.

[43]  V. Menon,et al.  White matter development during childhood and adolescence: a cross-sectional diffusion tensor imaging study. , 2005, Cerebral cortex.

[44]  S. Spiegel,et al.  Novel role of sphingosine kinase 1 as a mediator of neurotrophin‐3 action in oligodendrocyte progenitors , 2005, Journal of neurochemistry.

[45]  Carl-Fredrik Westin,et al.  DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity , 2005, NeuroImage.

[46]  Nora I. Perrone-Bizzozero,et al.  Altered Myelination of the Hippocampal Formation in Subjects with Schizophrenia and Bipolar Disorder , 2004, Neurochemical Research.

[47]  J. Grafman,et al.  Human prefrontal cortex: processing and representational perspectives , 2003, Nature Reviews Neuroscience.

[48]  D. Grandy,et al.  μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization , 2002, The Journal of Neuroscience.

[49]  S. Robinson Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny. , 2002, Neurotoxicology and teratology.

[50]  S. R. Thornton,et al.  Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: Impact on gliogenesis in vivo , 2001, Glia.

[51]  J. Trimmer,et al.  Developmental clustering of ion channels at and near the node of Ranvier. , 2001, Developmental biology.

[52]  J. Fuster The Prefrontal Cortex—An Update Time Is of the Essence , 2001, Neuron.

[53]  N. Baumann,et al.  Biology of oligodendrocyte and myelin in the mammalian central nervous system. , 2001, Physiological reviews.

[54]  L. Solymosi,et al.  Unusual pattern of leukoencephalopathy after morphine sulphate intoxication , 2000, Neuroradiology.

[55]  C. Gianoulakis,et al.  Ontogenesis of Proopiomelanocortin and Its Processing to β-Endorphin by the Fetal and Neonatal Rat Brain , 2000, Neuroendocrinology.

[56]  R. Zimmerman,et al.  Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. , 2000, Journal of computer assisted tomography.

[57]  C. Sato-Bigbee,et al.  Different Neuroligands and Signal Transduction Pathways Stimulate CREB Phosphorylation at Specific Developmental Stages Along Oligodendrocyte Differentiation , 1999, Journal of neurochemistry.

[58]  M. Oda,et al.  Hemimegalencephaly: signal changes suggesting abnormal myelination on MRI , 1998, Neuroradiology.

[59]  C. Grandin,et al.  Focal seizure-induced premature myelination: speculation from serial MRI , 1998, Neuroradiology.

[60]  C. Sato-Bigbee,et al.  Purification of Oligodendrocytes and Their Progenitors Using Immunomagnetic Separation and Percoll Gradient Centrifugation , 1998, Current protocols in neuroscience.

[61]  Virginia M. Y. Lee,et al.  Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons , 1998, The Journal of Neuroscience.

[62]  P. Knapp,et al.  Endogenous opioid system in developing normal and jimpy oligodendrocytes: μ and κ opioid receptors mediate differential mitogenic and growth responses , 1998, Glia.

[63]  P. Knapp,et al.  μ-Opioid receptor activation enhances DNA synthesis in immature oligodendrocytes , 1996, Brain Research.

[64]  C. Adamsbaum,et al.  Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations , 1996, Pediatric Radiology.

[65]  S. Robinson,et al.  Postnatal methadone exposure doe not prevent prenatal methadone-induced changes in striatal cholinergic neurons. , 1996, Brain research. Developmental brain research.

[66]  G. Akkerhuis,et al.  Development after prenatal exposure to cocaine, heroin and methadone , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[67]  D. Mathalon,et al.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. , 1994, Archives of neurology.

[68]  M. M. de Cubas,et al.  Children of methadone-dependent women: developmental outcomes. , 1993, The American journal of orthopsychiatry.

[69]  K. Hauser,et al.  Characterization of opioid-dependent glial development in dissociated and organotypic cultures of mouse central nervous system: critical periods and target specificity. , 1991, Brain research. Developmental brain research.

[70]  J. Fok-Seang,et al.  Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  R. Sidman,et al.  Role of Myelin Basic Protein in the Formation of Central Nervous System Myelin , 1990, Annals of the New York Academy of Sciences.

[72]  S. Hans Developmental Consequences of Prenatal Exposure to Methadone a , 1989, Annals of the New York Academy of Sciences.

[73]  J. Goldman,et al.  Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum , 1988, The Journal of comparative neurology.

[74]  J. Kamholz,et al.  Alternative splicing accounts for the four forms of myelin basic protein , 1985, Cell.

[75]  F. Stam,et al.  LEUCOENCEPHALOPATHY AFTER INHALING "HEROIN" PYROLYSATE , 1982, The Lancet.

[76]  S E Poduslo,et al.  MYELINATION IN RAT BRAIN: CHANGES IN MYELIN COMPOSITION DURING BRAIN MATURATION 1 , 1973, Journal of neurochemistry.

[77]  H. Jones,et al.  Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. , 2013, Drug and alcohol dependence.

[78]  C. Pantelis,et al.  Diseases of white matter and schizophrenia-like psychosis. , 2005, The Australian and New Zealand journal of psychiatry.

[79]  G. Hankins,et al.  Bidirectional transfer of methadone across human placenta. , 2005, Biochemical pharmacology.

[80]  T. Nanovskaya,et al.  Transplacental transfer and metabolism of buprenorphine. , 2002, The Journal of pharmacology and experimental therapeutics.

[81]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.

[82]  H. Henkes,et al.  Toxic spongiform leucoencephalopathy after inhaling heroin vapour , 1998, European Radiology.

[83]  B. Ransom,et al.  Electrical coupling, without dye coupling, between mammalian astrocytes and oligodendrocytes in cell culture , 1990, Glia.

[84]  R. Reynolds,et al.  Expression of the 2′,3′‐cyclic nucleotide 3′‐phosphohydrolase gene and immunoreactive protein in oligodendrocytes as revealed by in situ hybridization and immunofluorescence , 1988, Glia.

[85]  P S Bauman,et al.  The development of children of drug addicts. , 1986, The International journal of the addictions.

[86]  R. Jeremy,et al.  A longitudinal study of offspring born to methadone-maintained women. II. Dyadic interaction and infant behavior at 4 months. , 1984, The American journal of drug and alcohol abuse.